Company Analysis

Haemonetics Corporation (HAE)

NYSE: HAE · Surgical & Medical Instruments & Apparatus · Boston, MA · filing with the SEC since 1996
Grade5.7
◀ Past 6.8● Present 6.5▶ Future 3.4

Who runs Haemonetics Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Simon, Christopher
President & CEO. First filing May 2016, latest May 19, 2026, 21 filings in all.
Officers reporting now
7
of 15 people with a filing in the last fifteen months
Directors reporting now
8
35 people on the record since 2006
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Galvin RoyEVP, Chief Commercial OfficerOct 2022Nov 3, 2026none
Maunsell Farris MaryanneVP, Chief Accounting OfficerOct 2022Jun 8, 2026none
Miller Laurie A.SVP, Human ResourcesSep 2021Jun 8, 2026none
Simon, ChristopherPresident & CEOMay 2016May 19, 2026none
Darecca JamesEVP, Chief Financial OfficerApr 2022May 19, 2026none
Chan FrankEVP, Chief Operating OfficerApr 2025May 19, 2026none
Basil Michelle LEVP and General CounselMar 2017May 19, 2026none
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Abernathy Robert EdirectorOct 2017Jul 28, 2026none
Bryant Diane MdirectorAug 2023Jul 28, 2026none
Coyle Michael JdirectorApr 2020Jul 28, 2026none
Johnson Lloyd EmersondirectorAug 2021Jul 28, 2026none
Kroll Mark WdirectorJan 2006Jul 28, 2026none
Madaus Martin DdirectorJul 2026Jul 28, 2026none
Pomeroy ClairedirectorApr 2019Jul 28, 2026none
Zane Ellen MdirectorJul 2012Jul 28, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton HAE · research, not advice